RGRX - RegeneRx Biopharmaceuticals Inc News Story
$0.22 -0.0 -4.3%
Last Trade - 4:00pm
| Market Cap | £22.0m |
| Enterprise Value | £22.4m |
| Revenue | £55.1k |
| Position in Universe | 5944th / 6852 |
BRIEF-Regenerx Joint Venture Expects To Complete Phase 3 Dry Eye Trial In November 2020
Mon 31st August, 2020 1:35pm
Aug 31 (Reuters) - RegeneRx Biopharmaceuticals Inc
RGRX.PK :
* REGENERX JOINT VENTURE EXPECTS TO COMPLETE PHASE 3 DRY EYE
TRIAL
IN NOVEMBER 2020
Source text for Eikon: ID:nPn7Fnlvca
Further company coverage: RGRX.PK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on RegeneRx Biopharmaceuticals Inc
See all news
